StockData
AXIMOTCPharmaceutical PreparationsFiscal year ends December 31

AXIM BIOTECHNOLOGIES, INC.

Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

AXIM BIOTECHNOLOGIES, INC. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Axim Biotechnologies does not break out revenue by segment, region or product in the tagged data of its filings for this period type.